Intrinsiqq
IM Cannabis Corp. logo

IM Cannabis Corp.

IMCC

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market CapC$4M
EPS-C$2.84
P/E-0.18
P/FCF87.82
EV/EBITDA-1.33
FCF Yield1.1%
Div. Yield–
Net Debt/FCF276.3x
IM Cannabis Corp. intrinsic value
52-Week Range
$0.47$1.50

Profitability & Returns

Revenue (TTM)

C$51M

▲ +1.3% YoY

Net Income (TTM)

-C$14M

▲ +0.2% YoY

Op. Margin

-26.36%

▼ -2.2pp YoY

ROIC

-48.92%

▼ -15.7pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

C$49K

▲ +481.4% YoY

Op. Cash Flow (TTM)

C$67K

▲ +502.0% YoY

Net Debt

C$14M

Cash & Equiv.

C$3M

3Y CAGR: +0.2%

Continue Research

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with IMCC

CompareIntrinsic value
LIK.XETRLimes Schlosskliniken AG
€580.00-1.69%65
NORDH.XOSLNordhealth AS
€2.34-0.85%48
ALDMS.XPARDiagnostic Medical Systems S.A.
€0.89-0.67%30
ALEMS.XBRUEuropean Medical Solutions S.A.
€3.50+2.34%76
ENZY.XSTOEnzymatica AB
€0.18-4.59%25
SDOS.XSTOScandiDos AB
€0.01-20.00%25
7V0.XETRDarwin AG
€5.30+0.00%24
AJ91.XETRDocCheck AG
€10.10+0.00%58

IM Cannabis (IMCC) in four numbers

Fair value (revenue)
$8.55
Price $0.51 is 94% below it.
Intrinsic Value
Quality score
30/100
Best check: margin trend, +15.1pp. Weakest: return on capital, -48.9%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
-0.18
Negative: a loss over the last twelve months. Price to free cash flow 87.82.
Financials

Questions about IM Cannabis

Is IM Cannabis (IMCC) overvalued?

At $0.51, IM Cannabis' price is 94% below the $8.55 a share fair value that Intrinsiqq's calculator gets from its revenue. It trades at 87.82 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is IM Cannabis' fair value?

Intrinsiqq's calculator puts IM Cannabis' fair value at $8.55 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 2.3, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $6.41. Every input can be changed on the Intrinsic Value tab.

Is IM Cannabis a high-quality business?

IM Cannabis scores 30 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from company filings. Its best check is margin trend at +15.1pp, and its weakest is return on capital at -48.9%. The Quality tab shows every check against its target.

Does IM Cannabis (IMCC) pay a dividend?

No. IM Cannabis (IMCC) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IMCC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.